GE HEALTHCARE TECHNOLOGIES ($GEHC) posted quarterly earnings results for Q4 2025 on Wednesday, February 4th. The company reported earnings of $1.44 per share, beating estimates of $1.43 by $0.01. The company also reported revenue of $5,698,000,000, missing estimates of $5,723,262,024 by $-25,262,024.
You can see Quiver Quantitative's $GEHC stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
GE HEALTHCARE TECHNOLOGIES Hedge Fund Activity
We have seen 583 institutional investors add shares of GE HEALTHCARE TECHNOLOGIES stock to their portfolio, and 584 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CITADEL ADVISORS LLC removed 7,260,580 shares (-78.1%) from their portfolio in Q3 2025, for an estimated $545,269,558
- CAPITAL RESEARCH GLOBAL INVESTORS added 4,998,154 shares (+25.0%) to their portfolio in Q3 2025, for an estimated $375,361,365
- DODGE & COX added 3,949,361 shares (+16.8%) to their portfolio in Q3 2025, for an estimated $296,597,011
- BOSTON PARTNERS added 3,828,936 shares (+inf%) to their portfolio in Q3 2025, for an estimated $287,553,093
- JANE STREET GROUP, LLC removed 3,368,968 shares (-99.7%) from their portfolio in Q3 2025, for an estimated $253,009,496
- MANUFACTURERS LIFE INSURANCE COMPANY, THE added 2,774,403 shares (+292.5%) to their portfolio in Q3 2025, for an estimated $208,357,665
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 2,075,399 shares (+69.0%) to their portfolio in Q3 2025, for an estimated $155,862,464
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
GE HEALTHCARE TECHNOLOGIES Analyst Ratings
Wall Street analysts have issued reports on $GEHC in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Piper Sandler issued a "Overweight" rating on 01/30/2026
- BTIG issued a "Buy" rating on 11/21/2025
- Wells Fargo issued a "Overweight" rating on 10/30/2025
- Evercore ISI Group issued a "Outperform" rating on 10/30/2025
To track analyst ratings and price targets for GE HEALTHCARE TECHNOLOGIES, check out Quiver Quantitative's $GEHC forecast page.
GE HEALTHCARE TECHNOLOGIES Price Targets
Multiple analysts have issued price targets for $GEHC recently. We have seen 11 analysts offer price targets for $GEHC in the last 6 months, with a median target of $88.0.
Here are some recent targets:
- Jason Bednar from Piper Sandler set a target price of $94.0 on 01/30/2026
- Graham Doyle from UBS set a target price of $77.0 on 01/15/2026
- Rick Wise from Stifel set a target price of $95.0 on 01/07/2026
- Craig Bijou from B of A Securities set a target price of $92.0 on 01/05/2026
- Joanne Wuensch from Citigroup set a target price of $88.0 on 12/11/2025
- Matthew Taylor from Jefferies set a target price of $105.0 on 12/11/2025
- Ryan Zimmerman from BTIG set a target price of $87.0 on 11/21/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
